These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 12522793)

  • 21. Sialidosis presenting as severe nonimmune fetal hydrops is associated with two novel mutations in lysosomal alpha-neuraminidase.
    Loren DJ; Campos Y; d'Azzo A; Wyble L; Grange DK; Gilbert-Barness E; White FV; Hamvas A
    J Perinatol; 2005 Jul; 25(7):491-4. PubMed ID: 15908988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sialidosis type I carrying V217M/G243R mutations in lysosomal sialidase: an autopsy study demonstrating terminal sialic acid in lysosomal lamellar inclusions and cerebellar dysplasia.
    Uchihara T; Ohashi K; Kitagawa M; Kurata M; Nakamura A; Hirokawa K; Kasuga T; Kobayashi T
    Acta Neuropathol; 2010 Jan; 119(1):135-45. PubMed ID: 19415310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sialidosis Type 1 with a Novel Mutation in the Neuraminidase-1 (NEU1) Gene.
    Gowda VK; Srinivasan VM; Benakappa N; Benakappa A
    Indian J Pediatr; 2017 May; 84(5):403-404. PubMed ID: 28138907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sialidosis type I presenting with a novel mutation and advanced neuroimaging features.
    Gultekin M; Bayramov R; Karaca C; Acer N
    Neurosciences (Riyadh); 2018 Jan; 23(1):57-61. PubMed ID: 29455223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and electrophysiological characteristics of a type 1 sialidosis patient with a novel deletion mutation in NEU1 gene.
    Fan SP; Lee NC; Lin CH
    J Formos Med Assoc; 2020 Jan; 119(1 Pt 3):406-412. PubMed ID: 31371146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of human induced pluripotent stem cells (hIPSCs) from sialidosis types I and II patients with pathogenic neuraminidase 1 mutations.
    Han MJ; Annunziata I; Weesner J; Campos Y; Salie M; O'Reilly C; d'Azzo A
    Stem Cell Res; 2020 Jul; 46():101836. PubMed ID: 32485644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel mutations in the neuraminidase-1 (NEU1) gene in two patients of sialidosis in India.
    Ranganath P; Sharma V; Danda S; Nandineni MR; Dalal AB
    Indian J Med Res; 2012 Dec; 136(6):1048-50. PubMed ID: 23391804
    [No Abstract]   [Full Text] [Related]  

  • 28. Biochemical and molecular characterization of novel mutations in GLB1 and NEU1 in patient cells with lysosomal storage disorders.
    Kwak JE; Son MY; Son YS; Son MJ; Cho YS
    Biochem Biophys Res Commun; 2015 Feb; 457(4):554-60. PubMed ID: 25600812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sialidosis: a review of human neuraminidase deficiency.
    Lowden JA; O'Brien JS
    Am J Hum Genet; 1979 Jan; 31(1):1-18. PubMed ID: 107795
    [No Abstract]   [Full Text] [Related]  

  • 30. Type 1 Sialidosis Patient With a Novel Deletion Mutation in the NEU1 Gene: Case Report and Literature Review.
    Ahn JH; Kim AR; Lee C; Kim NKD; Kim NS; Park WY; Kim M; Youn J; Cho JW; Kim JS
    Cerebellum; 2019 Jun; 18(3):659-664. PubMed ID: 30635863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic and neurologic abnormalities distinguish the lysosomal disorders sialidosis and galactosialidosis in mice.
    de Geest N; Bonten E; Mann L; de Sousa-Hitzler J; Hahn C; d'Azzo A
    Hum Mol Genet; 2002 Jun; 11(12):1455-64. PubMed ID: 12023988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ascites in infantile onset type II Sialidosis.
    Tazi K; Guy-Viterbo V; Gheldof A; Empain A; Paternoster A; De Laet C
    JIMD Rep; 2022 Jul; 63(4):316-321. PubMed ID: 35822090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In silico identification of new putative pathogenic variants in the NEU1 sialidase gene affecting enzyme function and subcellular localization.
    Bonardi D; Ravasio V; Borsani G; d'Azzo A; Bresciani R; Monti E; Giacopuzzi E
    PLoS One; 2014; 9(8):e104229. PubMed ID: 25153125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sialidosis: A Review of Morphology and Molecular Biology of a Rare Pediatric Disorder.
    Khan A; Sergi C
    Diagnostics (Basel); 2018 Apr; 8(2):. PubMed ID: 29693572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First report of two Taiwanese siblings with sialidosis type I: a 10-year follow-up study.
    Chen CM; Lai SC; Chen IC; Hsu KC; Lyu RK; Ro LS; Chang HS
    J Neurol Sci; 2006 Aug; 247(1):65-9. PubMed ID: 16712870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular and structural studies of Japanese patients with sialidosis type 1.
    Naganawa Y; Itoh K; Shimmoto M; Takiguchi K; Doi H; Nishizawa Y; Kobayashi T; Kamei S; Lukong KE; Pshezhetsky AV; Sakuraba H
    J Hum Genet; 2000; 45(4):241-9. PubMed ID: 10944856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuraminidase deficiency presenting as non-immune hydrops fetalis.
    Beck M; Bender SW; Reiter HL; Otto W; Bässler R; Dancygier H; Gehler J
    Eur J Pediatr; 1984 Dec; 143(2):135-9. PubMed ID: 6240403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Child Neurology: Type 1 sialidosis due to a novel mutation in
    Aravindhan A; Veerapandiyan A; Earley C; Thulasi V; Kresge C; Kornitzer J
    Neurology; 2018 Mar; 90(13):622-624. PubMed ID: 29581327
    [No Abstract]   [Full Text] [Related]  

  • 39. Neuraminidase activities in sialidosis and mucolipidosis.
    Kuriyama M; Miyatake T; Owada M; Kitagawa T
    J Neurol Sci; 1982 May; 54(2):181-7. PubMed ID: 7097297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuraminidase deficiency: case report and review of the phenotype.
    Young ID; Young EP; Mossman J; Fielder AR; Moore JR
    J Med Genet; 1987 May; 24(5):283-90. PubMed ID: 3585942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.